SecSonar.com

Azenta, Inc. (AZTA)

Azenta, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Azenta, Inc. (AZTA) is a Medical - Instruments & Supplies company based in US with a market capitalization of $1.1B. Revenue grew 3.5% year-over-year and the company generated $38.3M in free cash flow. This page tracks AZTA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 3K employees · IPO Feb 2, 1995

Valuation

Valuation & price

$16.02 · as of May 17, 2026 · -60.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.62

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$40.37$28.30$16.24Jul 25Dec 25Jul 26Jul 7, 25$31.43Jul 9, 25$33.37Jul 11, 25$33.47Jul 15, 25$31.91Jul 17, 25$32.11Jul 21, 25$31.32Jul 23, 25$34.48Jul 25, 25$34.43Jul 29, 25$33.92Jul 31, 25$32.70Aug 4, 25$32.41Aug 6, 25$28.40Aug 11, 25$27.98Aug 13, 25$32.08Aug 15, 25$30.39Aug 19, 25$30.29Aug 21, 25$29.84Aug 25, 25$30.76Aug 27, 25$30.20Aug 29, 25$30.54Sep 3, 25$29.37Sep 5, 25$30.30Sep 9, 25$29.44Sep 11, 25$31.21Sep 16, 25$30.59Sep 18, 25$31.06Sep 22, 25$31.38Sep 24, 25$29.81Sep 26, 25$28.56Sep 30, 25$28.72Oct 2, 25$31.49Oct 6, 25$31.80Oct 8, 25$32.23Oct 10, 25$29.81Oct 14, 25$30.60Oct 16, 25$31.50Oct 21, 25$31.81Oct 23, 25$32.39Oct 27, 25$31.88Oct 29, 25$29.79Oct 31, 25$30.20Nov 4, 25$30.18Nov 6, 25$29.55Nov 10, 25$30.26Nov 12, 25$30.77Nov 14, 25$29.75Nov 18, 25$29.42Nov 20, 25$30.00Nov 25, 25$38.10Nov 28, 25$35.56Dec 2, 25$35.15Dec 4, 25$35.10Dec 8, 25$35.05Dec 10, 25$36.50Dec 12, 25$35.30Dec 16, 25$34.31Dec 18, 25$34.50Dec 22, 25$34.69Dec 24, 25$34.51Dec 29, 25$34.68Jan 2, 26$33.39Jan 6, 26$36.98Jan 8, 26$37.50Jan 12, 26$37.54Jan 14, 26$39.50Jan 16, 26$40.00Jan 21, 26$40.37Jan 23, 26$40.05Jan 27, 26$40.13Jan 29, 26$39.00Feb 2, 26$37.53Feb 4, 26$28.49Feb 9, 26$29.80Feb 11, 26$30.45Feb 13, 26$28.62Feb 18, 26$29.83Feb 20, 26$29.28Feb 24, 26$28.18Feb 26, 26$27.38Mar 2, 26$25.84Mar 4, 26$25.13Mar 6, 26$24.30Mar 10, 26$22.78Mar 12, 26$21.37Mar 17, 26$22.03Mar 19, 26$20.63Mar 23, 26$20.45Mar 25, 26$21.86Mar 27, 26$19.90Mar 31, 26$21.13Apr 2, 26$22.63Apr 7, 26$21.71Apr 9, 26$22.66Apr 13, 26$23.33Apr 15, 26$24.95Apr 17, 26$25.04Apr 22, 26$26.46Apr 24, 26$25.91Apr 28, 26$24.24Apr 30, 26$24.57May 4, 26$24.33May 6, 26$18.38May 8, 26$19.22May 12, 26$17.53May 14, 26$16.80May 18, 26$16.24May 20, 26$18.57May 22, 26$20.18May 28, 26$22.49Jun 1, 26$23.19Jun 3, 26$23.89Jun 5, 26$22.69Jun 9, 26$22.72Jun 11, 26$22.46Jun 15, 26$22.95Jun 17, 26$22.68Jun 22, 26$22.27Jun 24, 26$23.86Jun 26, 26$25.50Jul 2, 26$25.84
$16.0252-week range$41.01
Loading valuation history…

Fundamentals

Key fundamentals

$1.1B

Market cap

3.5%

Revenue growth (YoY)

45.5%

Gross margin

$38.3M

Free cash flow (USD)

-$229.7M

Net debt

Net cash position

-14.0%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$560.3MFY 2017$527.5MFY 2018$631.6MFY 2019$780.8MFY 2020$388.5MFY 2021$513.7MFY 2022$555.5MFY 2023$665.1MFY 2024$573.4MFY 2025$593.8M
$560.3M$593.8M

Free cash flow by year

2016 → 2025

FY 2016$26.7MFY 2017$83.3MFY 2018$61.2MFY 2019$67.0MFY 2020$-2.1MFY 2021$97.1MFY 2022$-543.5MFY 2023$-33.6MFY 2024$12.4MFY 2025$38.3M
$26.7M$38.3M

Gross margin by year

2021 → 2025

FY 202141.8%FY 202241.5%FY 202335.1%FY 202444.4%FY 202545.5%
41.8%45.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $164KCornog William L · Director · $163.8KMay 19, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • 8-K eventExecutive AppointmentApr 7, 2026Filing
  • 8-K eventTransaction UpdateApr 2, 2026Filing

Questions

Frequently asked questions

What is Azenta, Inc.'s market cap?

Azenta, Inc. (AZTA) has a market capitalization of $1.1B.

What is AZTA's P/E ratio?

A meaningful P/E ratio is not available for AZTA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is AZTA's price-to-book (P/B) ratio?

AZTA trades at 0.62 times book value per share.

Are insiders buying AZTA stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at Azenta, Inc. in the last 90 days.

Same arena

Related companies in Medical - Instruments & Supplies

QDEL

QuidelOrtho Corporation

$893.3M

KMTS

Kestra Medical Technologies, Ltd.

$1.2B

ATRC

AtriCure, Inc.

$1.4B

STAA

STAAR Surgical Company

$1.5B

NNNN

Anbio Biotechnology Class A Ordinary Shares

$1.5B

ANGO

AngioDynamics, Inc.

$479.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.